Background: Alterations in the cyclic AMP-dependent regulation of the cardiac ryanodine receptor (RyR2) have been proposed to account for increased spontaneous calcium release from the sarcoplasmic reticulum (SR) in patients with heart failure, ventricular tachyarrhythmias and atrial fibrillation. While the adenosine A 2A receptor (A 2A R) is known to regulate cyclic AMP levels, expression and function of this receptor in human cardiac myocytes has not been investigated. 
Introduction
Abnormal calcium release from the SR has been associated with heart failure [1] [2] [3] and with the genesis of afterdepolarization induced triggered arrhythmias [4] [5] [6] [7] [8] . Two main mechanisms have been proposed to explain abnormal calcium release from the SR: mutations and hyperphosphorylation of the SR calcium release channel (ryanodine receptor).
Several mutations in the SR calcium release channel have been shown to increase its opening probability in planar lipid bilayers [5, 9, 10] and these mutations are found in patients with polymorphic ventricular tachycardia [11] [12] [13] . Hyperphosphorylation of the ryanodine receptor mediated by cyclic AMP (cAMP)-dependent protein kinase A (PKA) has been Cardiovascular Research 72 (2006) 292 -302 www.elsevier.com/locate/cardiores reported in patients with heart failure, exercise-induced ventricular arrhythmias, or atrial fibrillation [2, 10, 14] . It is therefore conceivable that pharmacological control of receptor mediated cAMP-dependent activation of the ryanodine receptor may be a means to prevent or reduce abnormal calcium release from the SR. In this regard, antagonists of the G s -protein coupled β-adrenergic receptor have been shown to restore SR calcium release channel function and improve cardiac muscle performance in human heart failure [15] . Theoretically, other G s -protein coupled receptors, such as the adenosine A 2A receptor, may also exert a cAMP-dependent modulation of intracellular calcium handling. Indeed, the A 2A R has been shown to cause cAMP dependent inotropic effects in some studies [16] [17] [18] and indirect pharmacological data suggest that the A 2A R is expressed in rat [16] and guinea pig [19] ventricular myocytes. In contrast, other authors did not find effects of A 2A R stimulation [20] , and A 2A R mRNA was not found in porcine cardiomyocytes [21] .
The aim of the present study was to determine whether the A 2A R is expressed in the human atrial myocardium and to investigate if this receptor modulates two main players in intracellular calcium handling: the L-type calcium current (I Ca ) and calcium release from the sarcoplasmic reticulum through the ryanodine receptor. Our results reveal the presence of adenosine A 2A receptors in human right atrium and show that agonist stimulation of the A 2A R induces a PKA-mediated increase in spontaneous SR calcium release in human atrial myocytes.
Methods

Human samples
Atrial myocardial tissue samples were obtained from 72 patients undergoing cardiac surgery. The average age was 64± 2 years and 60% were male. All patients were in sinus rhythm and subjected to single or combined surgical interventions: coronary artery bypass surgery (28 patients), aortic valve replacement (45 patients), mitral valve replacement (18 patients), other surgical procedures (10 patients). Sixteen patients received angiotensin converting enzyme inhibitors, 12 beta-blockers, 16 diuretics, and 18 statins. Patients treated with calcium channel antagonists were excluded from the study. Specimen was obtained from the right atrial appendage just prior to atrial cannulation for cardioplumonary bypass. Although the atrial tissue samples consisted of tissue that would normally be discarded during surgery, permission to be used in this study was obtained from each patient. The study was approved by the Ethical Committee of our institution and the investigation conforms with the principles outlined in the Declaration of Helsinki. Patients treated with calcium channel antagonists were excluded from the study.
Myocyte isolation
Myocytes were isolated from human atrial tissue samples as previously described [6] . Briefly, small pieces of tissue were incubated at 35°C in a Ca 2+ free solution containing 0.5 mg/ml collagenase (Worthington type 2, 318 U/mg), and 0.5 mg/ml proteinase (Sigma type XXIV, 11 U/mg solid). After 45 min, the tissue was removed from the enzyme solution, and cells were disgregated in Ca 2+ -free solution with a Pasteur pipette. The remaining tissue was digested for 3 × 15 min in a fresh calcium free solution containing 0.4 mg/ml collagenase. Only elongated cells with clear cross striations and without granulation were used for experiments.
Spontaneous calcium release in isolated myocytes
Calcium sparks and calcium waves were detected in fluo-3 loaded cells using a laser-scanning confocal microscope (Leica TCS SP2 AOBS, Germany) as previously described [6] . The experimental solution contained (in mM): NaCl 136, KCl 4, NaH 2 PO 4 0.33, NaHCO 3 4, CaCl 2 2, MgCl 2 1.6, HEPES 10, Glucose 5, pyruvic acid 5, (pH = 7.4). Fluorescence emission was collected between 500 and 650 nm with the excitation at 488 nm attenuated to 1-3%. Calcium sparks and calcium waves were measured at resting conditions. Calcium sparks were detected as an increase in the signal mass of a 3 μm section through the center of a calcium spark, without any detectable increase in an adjacent 3 μm section [6] . An increase in the signal mass in two or more adjacent 3 μm sections were counted as calcium waves. The amplitude of each calcium spark, and its half-life were determined from an exponential fit of the decaying phase of the calcium spark transient. The calcium spark frequency was determined for each cell and normalized to the scanned cell length.
Patch-clamp
The transient inward Na-Ca exchange current associated with calcium waves was recorded in the perforated patch configuration using a software controlled patch-clamp amplifier (EPC 10, HEKA, Germany). The pipette resistance was 1.5-4 MΩ. Experiments were carried out at room temperature and began when the access resistance was stable and had decreased to less than 5 times the pipette resistance. The extracellular solution contained (in mM): NaCl 127, TEA 5, HEPES 10, NaHCO 3 4, NaH 2 PO 4 0.33, glucose 10, pyruvic acid 5, CaCl 2 2, MgCl 2 1.8, (pH = 7.4). The pipette solution contained (in mM): aspartic acid 109, CsCl 47, Mg 2 ATP 3, MgCl 2 1, Na 2 phosphocreatine 5, Li 2 GTP 0.42, HEPES 10 and 250 μg/ml amphotericin B, (pH = 7.2). The A 2A R agonist CGS21680 and the protein kinase A inhibitor H-89 were dissolved in DMSO and kept as 10 mM stock solutions. Ryanodine was kept as a 100 mM stock solution. CGS21680 was used at a final concentration of 200 nm. At this concentration, CGS21680 selectively stimulates the A 2A R [22] and induces a robust stimulation of cell shortening in rat ventricular myocytes [16, 23] . L-type calcium current amplitude and inactivation were measured at steady state, using repetitive depolarizations from − 80 to 0 mV for 200 ms at a frequency of 0.5 Hz.
The caffeine releasable SR calcium content was measured by transiently exposing cells to 10 mM caffeine. The time integral of the resulting Na-Ca exchange current was converted to amoles (10 − 18 mol) of calcium released from the SR assuming a stoichiometry of 3Na + :1Ca 2+ for the NaCa exchanger [6] .
Total RNA extraction and PCR
Total RNA was isolated from 15 human right atrial tissue samples using the QuickPrep Total RNA Extraction Kit (Amersham, Freiburg, Germany) according to the manufacturer's instructions. First-strand cDNA was synthesized from 1 μg of total RNA using a random hexamer primer and SuperScript II Rnase H − Reverse Transcriptase (Gibco BRL, Gaithersburg, MD, U.S.A.) according to the manufacturer's protocol. cDNA was amplified using Taq DNA polymerase and the following primers: for the human glyceraldehyde-3-phosphate dehydrogenase (GAPDH), FGAPDH (5′-GCG GGGCTCTCCAGAACATCAT-3′) and RGAPDH (5′-GGT GGTCCAGGGGTCTTACTCC-3′) and for the human A 2A R (hA2A), FhA2A (5′-GGCTGCCCCTACACATCATCAACT-3′) and RhA2A (5′-TGGGCCAGGGGGTCATCT-3′).
Gel electrophoresis and immunoblotting
Membranes from human right atrial tissue or from transiently transfected HEK cells were treated with SDS-PAGE sample buffer (8 M urea, 2% SDS, 100 mM DTT, 375 mM Tris, pH 6.8) by heating at 37°C during 2 h and resolved by SDS-polyacrylamide gel electrophoresis in 10% gels. Proteins were transferred to PVDF membranes using a semi-dry transfer system and immunoblotted with the indicated antibody and then horseradish-peroxidase (HRP)-conjugated goat anti-rabbit IgG (1/60,000). The immunoreactive bands were developed using a chemiluminescent detection kit (SuperSignal, West Pico Chemiluminescent substrate, Pierce).
Immunostaining
Human atrial tissue samples used for immunohistochemistry were embedded in OCT and frozen in liquid nitrogencooled isopentane. Eight micrometer sections were cut on a cryostat cooled to −18°C. Sections were collected onto SuperFrost Plus (BDH) slides, air dried and stored at −70°C. For immunofluorescence, sections were blocked for 30 min in 10% donkey serum in Tris-buffered saline (TBS) (150 mM NaCl/50 mM Tris-HCl, pH 7.5). Slides were incubated with affinity purified anti-A 2A R (VC21, 25 μg/ml) for one hour at room temperature and then washed three times for 10 min in TBS. Alexa Fluor® 488 conjugated goat anti-mouse IgG and Texas Red®-conjugated goat anti-rabbit IgG were applied in blocking solution at a dilution of 1:2000. Sections were rinsed and mounted with Vectashield immunofluorescence medium (Vector Laboratories Inc., Burlingame, CA, U.S.A.).
Freshly isolated human cardiac myocytes used for immunocytochemistry were plated in 24 mm glass coverslips coated with poly-D-lysine. After adhesion, cells were rinsed in phosphate-buffered saline and were fixed with 2% paraformaldehyde in PBS for 20 min at room temperature. Cells were washed with PBS and were incubated with 0.1 M glycine for 5 min to quench the aldehyde groups. After washing with PBS, myocytes were permeabilized with 0.2% Triton-X-100 in PBS for 15 min. Cells were then washed with PBS, blocked for 30 min with 10% horse serum at room temperature and incubated with rabbit polyclonal antiadenosine A 2A receptor (10 μg/ml), and either mouse anti-α-actinin (1:500 dilution), mouse anti-myosin (1:500 dilution), mouse anti-connexin-43 (1:150 dilution), or mouse anti-ryanodine receptor (1:500 dilution) for one hour at room temperature, washed three times with PBS, and stained with anti-mouse Alexa Fluor 488 antibody and antirabbit Texas Red. Finally cells were rinsed again for three times and mounted with Vectashield immunofluorescence medium (Vector Laboratories Inc.).
For these studies a Leica TCS 4D confocal laser scanning microscope was used (Leica Lasertechnik GmbH, Heidelberg, Germany).
Data analysis and statistics
Ca
2+ sparks and Ca 2+ waves recorded in cells from the same patient were averaged. Unless otherwise stated, average values from each patient were used for statistical analysis and expressed as mean ± s.e.m. Data sets were tested for normality. Student's t-test was used to assess significant differences when testing a specific effect. ANOVA was used for comparison of multiple effects and Student-NewmanKeuls post test was used to evaluate the significance of specific effects. Differences were considered statistically significant when p b 0.05. Fig. 1a and b show that mRNA coding for A 2A R was present in right atrium and that both monomeric and dimeric species of the receptor are expressed. The A 2A R was expressed in a transversal-banded pattern along the myocardial fiber. A 2A R immunostaining was specific since it disappeared when the primary A 2A R antibody was omitted or when the A 2A R antibody was pre-incubated with the peptide used to raise it (Fig. 1c) . The A 2A R codistributed with the cytoskeletal-associated protein α-actinin at the level of the Z line in the sarcomer and its distribution overlapped with that of the ryanodine receptor (Fig. 2) . In contrast, A 2A R did not co-localize with the Hband marker myosin or with the gap junction protein connexin-43.
Results
Expression and localization of A 2A R in human right atrium
A 2A R stimulation and L-type calcium current
To determine if the A 2A R modulates L-type calcium current, I Ca amplitude and inactivation kinetics were measured before, during, and after exposure of right atrial myocytes to 200 nm of the selective A 2A R agonist CGS21680 (Fig. 3a) . Fig. 3b shows that a 10 min exposure to CGS21680 had no effect on the I Ca amplitude and Fig. 3c reveals that the A 2A R agonist significantly shortened the fast, calcium releasedependent, I Ca inactivation time constant (tau) from 15.8 ± 1.0 to 13.4 ± 0.7 ms (p b 0.001, n = 27). Inhibition of calcium release from the SR with 400 μM ryanodine (not shown) increased tau from 13.2 ± 0.9 to 23.5 ± 1.6 ms (n = 7, p b 0.001) confirming that tau is SR calcium release dependent. Moreover, CGS21680 did not alter tau when added in the presence of ryanodine (23.4 ± 1.4 ms, p = 0.92, n = 7). Fig. 3d shows the effect of CGS21680 on the currentvoltage relationship for I Ca .
A 2A R activation and spontaneous SR calcium release
To examine if A 2A R agonists modulate SR calcium release the effect of CGS21680 on spontaneous SR calcium release in isolated human right atrial myocytes was analyzed. Both local non-propagating calcium release (calcium sparks) and propagating calcium release from the SR (calcium waves) were analyzed. To determine whether A 2A R stimulation modifies SR calcium loading or its rate of refilling, we analyzed respectively the amplitude and the decay of 254 calcium sparks from 14 patients. The left panel of Fig. 4a shows a fluo-4 loaded atrial myocyte with the scan line indicated in red. The middle panel shows calcium sparks recorded with this scan line and the right hand panel shows the corresponding changes in the intracellular [Ca 2+ ] for the calcium sparks at the black arrows. Fig. 4b shows that neither the calcium spark amplitude (left panel) nor the decay of the calcium sparks (right panel) were altered by incubation with CGS21680. Fig. 5a shows consecutive line-scan images from a control cell and a cell preincubated with 200 nm CGS21680 and Fig. 5b shows that this A 2A R agonist significantly increased both the number of calcium sparks (left panel) and calcium waves (right panel), corresponding to an increase in the calcium wave frequency from 0.65 ± 0.31 to 5.11 ± 1.84 waves min − 1 . To determine whether the observed effect of CGS21680 on spontaneous SR calcium release is secondary to an effect on the membrane potential, the patch-clamp technique was used to hold the membrane potential at − 80 mV. This voltage clamping did, however, not prevent CGS21680 from reversibly increasing the number of spontaneous calcium waves measured as the Na-Ca exchange current (I NCX ) activated by them (Fig. 6a) . The right hand panel shows that there was no difference in the amplitude of the spontaneous I NCX . Fig. 6b shows the time course of the stimulatory effect of CGS21680 and the right hand panel summarizes the stimulatory effect of CGS21680 on I NCX (p b 0.001, n = 27). The effect of CGS21680 was reversed by the selective A 2A R antagonist ZM241385 (Fig. 6c) . Assessment of the SR calcium loading by rapid exposure of myocytes to 10 mM caffeine at a holding potential of − 80 mV gave comparable SR calcium loading before and after agonist activation of the A 2A R (7.0±0.5 amol pF − 1 and 6.8 ± 0.6 amol pF − 1 respectively (p = 0.62, n = 16, paired t-test). Together, these results suggest that the observed effects of CGS21680 are due to a direct effect on the ryanodine receptor. To test this further, the effect of CGS21680 on spontaneous I NCX and the caffeine releasable SR calcium content was examined in the presence of tetracaine and ryanodine, two compounds known to inhibit calcium release through the ryanodine receptor. Tetracaine abolished spontaneous I NCX and moreover, exposure to CGS21680 in the presence of tetracaine did not induce any spontaneous I NCX . Washing of tetracaine induced a transient overshoot in I NCX amplitude and frequency (see supplementary figure panel A). This was observed in cells from 5 patients exposed to tetracaine. Application of 400 μM ryanodine to cells from 7 patients irreversibly abolished spontaneous I NCX , which did not reappear in the presence of CGS21680. Moreover, ryanodine prevented 10 mM caffeine from releasing calcium from the SR with and without CGS21680, suggesting that caffeine could not overcome the inhibitory effect of ryanodine. In contrast, the time integral of the caffeine induced I NCX was increased 3-fold in the presence of 250 μM tetracaine, showing that tetracaine is able to inhibit spontaneous I NCX in spite of a 
Protein kinase A dependency of A 2A R-mediated spontaneous calcium release
Since the A 2A R is coupled to G s proteins [24] , agonistmediated receptor activation should increase cAMP levels and this in turn could activate protein kinase A (PKA)-dependent phosphorylation of phospholamban and/or the ryanodine receptor. To test whether A 2A R exerts its effect through PKA activation, the selective PKA inhibitor H-89 was employed. As shown in the representative current traces of Fig. 7a , H-89 eliminated the stimulatory effect of CGS21680 in isolated myocytes. Fig. 7b summarizes the average effect of CGS21680 on spontaneous calcium release in the absence and the presence of H-89. In accordance with these results, confocal calcium imaging showed that the spark frequency was significantly lower in myocytes incubated with H-89 + CGS21680 than in myocytes incubated with CGS21680 alone (0.018 ± 0.012 versus 0.754 ± 0.260 sparks·μm − 1 min − 1 , p = 0.01, n = 5). Moreover, spontaneous calcium waves were abolished in myocytes incubated with CGS21680 + H-89. These results suggest that the A 2A Rdependent stimulation of spontaneous SR calcium release is in fact mediated by PKA activation. 
Discussion
This study establishes for the first time that the A 2A R is expressed in the human atrial myocardium and demonstrates that this receptor modulates calcium release from the SR in isolated human right atrial myocytes.
Expression of the A 2A R in human right atrium
PCR-technique identified the mRNA of the A 2A R and western blotting confirmed the presence of both monomeric and homodimeric forms of the A 2A R in the human atrium. Our results confirm previous indirect evidence for the presence of the A 2A R in mammalian ventricle [16] [17] [18] [19] 23] . The striated pattern of the A 2A R at the level of the Z-line and its co-distribution with α-actinin may be explained by a scaffolding action of α-actinin because α-actinin interacts directly with the cytoplasmatic C-terminal region of human A 2A R and plays a role in the traffic of this receptor [25] . The observed overlap in the distribution of the A 2A R and the ryanodine receptor and the positive coupling of A 2A R with adenylate cyclase reported in rat ventricular myocytes [18, 19] , also suggest that an A 2A R mediated cAMPdependent modulation of the ryanodine receptor is feasible.
Function of the A 2A R on L-type calcium current
To address potential functional effects of the A 2A R on intracellular calcium handling, we first determined the effect of the A 2A R agonist CGS21680 on I Ca amplitude. Our results showed no significant effect of CGS21680 on I Ca amplitude.
A previous study failed to find functional effects of A 2A R stimulation in a mammalian ventricular preparation [20] whereas others have shown that A 2A R stimulation induces a positive inotropic effect [16] [17] [18] . The observation of a positive inotropic effect of CGS21680 in the absence of a concurrent stimulation of I Ca as observed here, are not mutually exclusive as long as another calcium source, such as the SR, is activated by CGS21680.
Function of the A 2A R on SR calcium release
In this study we found that A 2A R stimulation increases spontaneous calcium release from the SR and reduces the fast time constant for I Ca inactivation. Since a reduction in the fast time constant for I Ca inactivation is observed with larger SR calcium release [26] our results suggest that A 2A R stimulation also triggers calcium induced calcium release from the SR. The stimulatory action of CGS21680 on SR calcium release may occur at the ryanodine receptor or it may be secondary to an effect of CGS21680 on the SR calcium content or on the I Ca amplitude, since both of these factors have been shown to regulate SR calcium release [27] [28] [29] [30] . Our results suggest that CGS21680 acts on the ryanodine receptor since neither the amplitude of spontaneous I NCX , the caffeine releasable SR calcium content, nor the I Ca amplitude were altered by CGS21680. Moreover, a stimulatory effect of this compound on SR calcium uptake or SR calcium loading would be expected to speed up the decay and increase the amplitude of calcium spark transients respectively [28, 29] . However, CGS21680 elevated the frequency of calcium sparks without changing their amplitude or decay. Finally, the effect of CGS21680 was similar in cells with the resting potential clamped at − 80 mV and in unclamped cells, discarding that A 2A R mediated effects are secondary to changes in the resting membrane potential, another important modulator of the spontaneous SR calcium release [28, 31] .
Inositol-triphosphate (IP3) receptors are also expressed in mammalian atrial myocytes and co-localize with the ryanodine receptor [32] . Indeed, a cross-talk between the IP3 receptor and the ryanodine receptor has been shown to modulate spontaneous calcium release from the SR through the ryanodine receptor in mammalian atrial myocytes [33] [34] [35] . Theoretically, the stimulatory effect of CGS21680 on spontaneous calcium release could therefore be due to an effect of this compound on IP3-dependent calcium release. However, CGS21680 has been shown to inhibit IP3 production [36] . Moreover, PKA-dependent phosphorylation of the IP3 receptor has been shown to reduce type-3 IP3 dependent calcium release [37] and the type-2 IP3 receptor, which predominates in the heart, is a poor substrate for PKAdependent phosphorylation [38] . Finally, we found that inhibition of SR calcium release with 400 μM ryanodine or 250 μM tetracaine abolished spontaneous I NCX as well as the effects of CGS21680 on spontaneous I NCX and fast I Ca inactivation, in spite of a three-fold larger SR calcium load with 250 μM tetracaine. Taken together, this suggests that activation of the A 2A R with CGS21680 stimulates the ryanodine receptor itself.
Protein kinase A dependent activation of SR calcium release
The A 2A R is positively coupled to adenyate cyclase through G s proteins and their stimulation has been reported to increase cAMP levels in rat ventricular myocytes [18, 19] . Stimulation of SR calcium release by the A 2A R agonist CGS21680 could therefore result from a PKA-dependent stimulation of the ryanodine receptor in a manner similar to that reported for G s protein-coupled β-adrenergic receptors [3, 15] in patients with failing hearts. In these patients, a PKAdependent phosphorylation of the ryanodine receptor has been proposed to cause an increased calcium leak from the SR [2, 15] . While this proposal is controversial [39, 40] our finding that H-89 abolished the stimulatory effect of CGS21680 on spontaneous SR calcium release does confirm a positive coupling between the A 2A R, PKA, and the ryanodine receptor in human atrial myocytes. Moreover, our findings suggest that the A 2A R mediates a PKA-dependent regulation of the ryanodine receptor itself, since A 2A R stimulation had no effect on I Ca amplitude, spontaneous I NCX amplitude, decay of calcium sparks, or the amount of calcium that could be released from the SR by a rapid caffeine application.
The lack of effect of CGS21680 on SR calcium loading and calcium spark decay is also in accordance with a study showing that A 2A R stimulation in guinea pig ventricle increases the cellular cAMP content but not phospholamban phosphorylation [19] . Furthermore, there is growing evidence that cAMP-mediated pathways are locally controlled [41] [42] [43] and a local A 2A R-mediated control of cAMP could explain why CGS21680 stimulates SR calcium release without affecting SR calcium loading, calcium spark decay, or I Ca amplitude.
In view of the reported PKA-dependent hyperphosphorylation of the ryanodine receptor in heart failure [2, 3, 15] and in catecholaminergic polymorphic ventricular tachycardia [4] , it will be important to determine whether the A 2A R is expressed and modulates spontaneous SR calcium release in the diseased ventricular myocardium.
In summary, we show that the adenosine A 2A receptor is expressed in the human atrial myocardium and has the potential to modulate SR calcium release in human atrial myocytes. Therefore, pharmacological control of A 2A R activation may offer a novel approach to control calcium release from the SR.
